|
Subsequent Events (Details Textual) (USD $)
|
1 Months Ended | 6 Months Ended | 1 Months Ended | 6 Months Ended | 1 Months Ended | 1 Months Ended | 1 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jul. 30, 2012
|
Jun. 30, 2012
|
Jul. 31, 2012
|
Mar. 23, 2012
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Jul. 30, 2012
2002 Stock Option and Incentive Plan [Member]
|
Jun. 30, 2012
Koski Family Limited Partnership [Member]
Common Stock [Member]
|
Jul. 30, 2012
Dr. John Bonfiglio [Member]
|
Aug. 06, 2012
Dr. John Bonfiglio [Member]
|
Jul. 30, 2012
Dr. John Bonfiglio [Member]
2002 Stock Option and Incentive Plan [Member]
|
Jul. 30, 2012
Dr. Martin Handfield [Member]
|
Aug. 06, 2012
Dr. Martin Handfield [Member]
|
Jul. 30, 2012
Dr. Martin Handfield [Member]
2002 Stock Option and Incentive Plan [Member]
|
Jul. 30, 2012
Non-employee directors [Member]
|
Jul. 30, 2012
Executive Officer [Member]
|
|
| Subsequent Events (Textual) [Abstract] | ||||||||||||||||
| Common stock issued to KFLP | 1,692,123 | |||||||||||||||
| Percentage of share granted under long term incentive program | 0.70% | 0.23% | ||||||||||||||
| Common stock Awarded | 30,000 | 465,816 | 132,000 | 188,482 | 43,000 | 61,929 | 215,405 | 250,411 | ||||||||
| Retained by the Company for applicable tax withholding obligations | 34,914 | 11,373 | ||||||||||||||
| Subsequent Events (Additional Textual) [Abstract] | ||||||||||||||||
| Number of Common stock sold | 866,665 | |||||||||||||||
| Price per share | $ 1.50 | |||||||||||||||
| Proceeds from sell of stock | $ 13,000,000 | |||||||||||||||
| Liquidated dameges Percentage to each puchaser | 100.00% | |||||||||||||||
| Aggregate purchase price paid for Registrable Securities | 600.00% | |||||||||||||||
| Cash Commission | 899,698 | |||||||||||||||
| Cash Commission in percentage of gross proceeds | 7.00% | |||||||||||||||
| Expiration period of warrant | 5 years | |||||||||||||||
| Shares purchase under warrant | 771,169 | |||||||||||||||
| Shares purchase percentage under warrant | 9.00% | |||||||||||||||
| Exercise Price | 4.12 | 1.50 | 2.00 | 19.14 | 19.14 | |||||||||||
| Maximum legal fees and disbursements | 50,000 | |||||||||||||||
| Secured debt, principal amount | 2,500,000 | |||||||||||||||
| Raised new capital | $ 10,000,000 | |||||||||||||||
| Award approved by the board | 43,081 | |||||||||||||||
| Balance of shares approved by shareholders under the plan for future issuance | 140,816 | |||||||||||||||